Skip to main content
Fig. 1 | BMC Medicine

Fig. 1

From: A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis

Fig. 1

Study flowchart for baseline analysis and phase 1 trial. ALS, amyotrophic lateral sclerosis; T0, baseline; T1, 3 months from baseline; T2, 6 months from baseline; ALSFRS-R, ALS Functional Rating Scale–Revised; BMI, body mass index; FVC%, force vital capacity %; DGGE, denaturing gradient gel electrophoresis; qPCR, quantitative polymerase chain reaction; NGS, next-generation sequencing

Back to article page